Research
FDA panel recommends CBD medication for epilepsy
April 20, 2018se E. Cavazos, M.D., Ph.D., professor of neurology and physiology at UT Health San Antonio and assistant dean of the institution’s M.D./Ph.D. program, reviewed clinical studies of the drug, which would be sold under the brand name Epidiolex.
Read moreAnnual dental symposium features posters, talks, new mentor award
April 18, 2018The symposium celebrates accomplishments in all areas of research, including education, public health, clinical sciences and basic sciences.
Read more
UT Health San Antonio launches brand campaign
April 16, 2018The campaign seeks to inform consumers that the work of UT Health San Antonio improves the entire spectrum of health care.
Read moreDr. Ramirez named a Komen Scholar for breast cancer research
April 9, 2018Komen Scholars are an advisory group of distinguished leaders in breast cancer research and advocacy. Dr. Ramirez will also receive $600,000 for Latino breast cancer research.
Read more
Injecting gene cocktail into mouse pancreas leads to humanlike tumors
April 5, 2018The groundbreaking technology could revolutionize studies of pancreatic cancer initiation and progression, and spur new drug development.
Read more
Researchers find link between congenital heart defects and adrenal gland cancer
March 29, 2018Team led by Patricia Dahia, M.D., Ph.D., of UT Health San Antonio.
Read more